AFMD: Affimed N.V. Stocks News on April 2, 2025

Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting

AFMD

GlobeNewswire

8 days ago

Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting

Affimed to Present at the Leerink Partners Global Healthcare Conference 2025

AFMD

GlobeNewswire

a month ago

Affimed to Present at the Leerink Partners Global Healthcare Conference 2025

Affimed Shares Fall 32% on Clinical Update

AFMD

GuruFocus.com

4 months ago

Affimed Shares Fall 32% on Clinical Update

Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)

AFMD

GlobeNewswire

4 months ago

Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)

AFMD

MT Newswires

4 months ago

Affimed Reports Efficacy, Safety Data From Leukemia Treatment Study

$Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)$

AFMD

GlobeNewswire

4 months ago

Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Affimed to Host Investor Conference Call Highlighting Clinical Data from AFM24 in Combination with Atezolizumab in Non-Small Cell Lung Cancer

AFMD

GlobeNewswire

4 months ago

Affimed to Host Investor Conference Call Highlighting Clinical Data from AFM24 in Combination with Atezolizumab in Non-Small Cell Lung Cancer

$Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients$

AFMD

GlobeNewswire

4 months ago

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients

AFMD

Zacks

4 months ago

AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy

FDA ARMAT status for Affimed and Artiva’s lymphoma combo therapy

AFMD

Pharmaceutical Technology

4 months ago

FDA ARMAT status for Affimed and Artiva’s lymphoma combo therapy

FDA RMAT status for Affimed and Artiva’s lymphoma combo therapy

AFMD

Pharmaceutical Technology

4 months ago

FDA RMAT status for Affimed and Artiva’s lymphoma combo therapy

Affimed Announces Acimtamig and AlloNK® Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug Administration (FDA)

AFMD

GlobeNewswire

4 months ago

Affimed Announces Acimtamig and AlloNK® Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug Administration (FDA)

AFMD

Insider Monkey

4 months ago

Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?

AFMD

GuruFocus.com

5 months ago

Affimed NV (AFMD) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges with ...

AFMD

Associated Press Finance

5 months ago

Affimed N.V.: Q3 Earnings Snapshot

Affimed Reports Third Quarter 2024 Financial Results & Business Update

AFMD

GlobeNewswire

5 months ago

Affimed Reports Third Quarter 2024 Financial Results & Business Update

Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024

AFMD

GlobeNewswire

5 months ago

Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024

Ultragenyx (RARE) Reports Q3 Loss, Tops Revenue Estimates

AFMD

Zacks

5 months ago

Ultragenyx (RARE) Reports Q3 Loss, Tops Revenue Estimates

Affimed Announces Acceptance of Three Abstracts at the 2024 ASH Annual Meeting Including an Oral Presentation Underscoring Advancing Clinical Pipeline in Leukemia and Lymphoma

AFMD

GlobeNewswire

5 months ago

Affimed Announces Acceptance of Three Abstracts at the 2024 ASH Annual Meeting Including an Oral Presentation Underscoring Advancing Clinical Pipeline in Leukemia and Lymphoma

AFMD

MT Newswires

5 months ago

Affimed Files $20 Million Mixed Shelf

683 Capital Management, LLC Expands Stake in Affimed NV

AFMD

GuruFocus.com

5 months ago

683 Capital Management, LLC Expands Stake in Affimed NV

AFMD

MT Newswires

6 months ago

Top Premarket Gainers

Affimed to Present at the Cantor Global Healthcare Conference 2024

AFMD

GlobeNewswire

7 months ago

Affimed to Present at the Cantor Global Healthcare Conference 2024

AFMD

Associated Press Finance

7 months ago

Affimed N.V.: Q2 Earnings Snapshot

Affimed Reports Second Quarter 2024 Financial Results & Business Update

AFMD

GlobeNewswire

7 months ago

Affimed Reports Second Quarter 2024 Financial Results & Business Update

Affimed Appoints New CEO, Shares Fall on Leadership Change

AFMD

Zacks

7 months ago

Affimed Appoints New CEO, Shares Fall on Leadership Change

AFMD

GuruFocus.com

7 months ago

Affimed NV (AFMD) Q2 2024 Earnings Report Preview: What To Look For

Affimed Appoints Shawn M. Leland as Chief Executive Officer

AFMD

GlobeNewswire

7 months ago

Affimed Appoints Shawn M. Leland as Chief Executive Officer

Affimed to Report Second Quarter 2024 Financial Results & Corporate Update on September 5, 2024

AFMD

GlobeNewswire

7 months ago

Affimed to Report Second Quarter 2024 Financial Results & Corporate Update on September 5, 2024

Oculis Holding AG (OCS) Reports Q2 Loss, Misses Revenue Estimates

AFMD

Zacks

7 months ago

Oculis Holding AG (OCS) Reports Q2 Loss, Misses Revenue Estimates

AFMD

Zacks

8 months ago

Affimed (AFMD) to Report Q2 Earnings: What's in the Cards?

AFMD

Insider Monkey

10 months ago

Affimed N.V. (NASDAQ:AFMD) Upgraded by Laidlaw

AFMD

Insider Monkey

10 months ago

Affimed N.V. (NASDAQ:AFMD) Q1 2024 Earnings Call Transcript

AFMD

Associated Press Finance

10 months ago

Affimed N.V.: Q1 Earnings Snapshot

Affimed Reports First Quarter 2024 Financial Results & Business Update

AFMD

GlobeNewswire

10 months ago

Affimed Reports First Quarter 2024 Financial Results & Business Update

Lotto 6/49 - $64 million up for grabs in the next draw!

AFMD

CNW Group

10 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

AFMD

Simply Wall St.

10 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFMD

AFP

10 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

AFMD

Simply Wall St.

10 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

AFMD

Simply Wall St.

10 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

AFMD

Barrons.com

10 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

AFMD

Simply Wall St.

10 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

AFMD

Simply Wall St.

10 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Spirit Airlines not considering Chapter 11 bankruptcy, CNBC reports

AFMD

Reuters

10 months ago

Spirit Airlines not considering Chapter 11 bankruptcy, CNBC reports

Aqua-Tots Swim School Splashes Into Summer With Highly-Anticipated Grand Opening in Henderson, Nevada

AFMD

GlobeNewswire

10 months ago

Aqua-Tots Swim School Splashes Into Summer With Highly-Anticipated Grand Opening in Henderson, Nevada

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

AFMD

ACCESSWIRE

10 months ago

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

Decisions of the Ordinary General Shareholders' Meeting of Novaturas AB

AFMD

GlobeNewswire

10 months ago

Decisions of the Ordinary General Shareholders' Meeting of Novaturas AB

AllianceBernstein: Office Space: Looking Past the Doom and Gloom

AFMD

ACCESSWIRE

10 months ago

AllianceBernstein: Office Space: Looking Past the Doom and Gloom

AFMD

CNW Group

10 months ago

Sage Potash Grants Stock Options

BW Energy: Mandatory notifications of trade by primary insiders and close associates

AFMD

GlobeNewswire

10 months ago

BW Energy: Mandatory notifications of trade by primary insiders and close associates

DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio

AFMD

Newsfile

10 months ago

DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio

Vanda (VNDA) Surges 24.2%: Is This an Indication of Further Gains?

AFMD

Zacks

10 months ago

Vanda (VNDA) Surges 24.2%: Is This an Indication of Further Gains?

Affimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024

AFMD

GlobeNewswire

10 months ago

Affimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024

AFMD

Zacks

10 months ago

Affimed (AFMD) Soars on Upbeat Follow-Up Data From NSCLC Study

AFMD

Zacks

10 months ago

Is Affimed (AFMD) Outperforming Other Medical Stocks This Year?

Why Is German Biotech Affimed Stock Soaring On Monday?

AFMD

Benzinga

10 months ago

Why Is German Biotech Affimed Stock Soaring On Monday?

Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort

AFMD

GlobeNewswire

10 months ago

Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort

AFMD

MT Newswires

10 months ago

Affimed Says US FDA Grants Fast-Track Designation for Potential Lung Cancer Therapy

Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR Wild-Type Non-Small Cell Lung Cancer

AFMD

GlobeNewswire

10 months ago

Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR Wild-Type Non-Small Cell Lung Cancer

Affimed Announces Annual General Meeting of Shareholders

AFMD

GlobeNewswire

10 months ago

Affimed Announces Annual General Meeting of Shareholders

Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024

AFMD

GlobeNewswire

10 months ago

Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024

Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress

AFMD

GlobeNewswire

a year ago

Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress

Immatics (IMTX) Reports Q1 Loss, Tops Revenue Estimates

AFMD

Zacks

a year ago

Immatics (IMTX) Reports Q1 Loss, Tops Revenue Estimates

AFMD

Zacks

a year ago

Wall Street Analysts Believe Affimed N.V. (AFMD) Could Rally 146.73%: Here's is How to Trade

Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology

AFMD

GlobeNewswire

a year ago

Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology

AFMD

Zacks

a year ago

Affimed N.V. (AFMD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

AFMD

Zacks

a year ago

Does Affimed N.V. (AFMD) Have the Potential to Rally 263.36% as Wall Street Analysts Expect?

AFMD

Insider Monkey

a year ago

Affimed N.V. (NASDAQ:AFMD) Q4 2023 Earnings Call Transcript

Affimed Reports 2023 Financial Results and Operational Progress

AFMD

GlobeNewswire

a year ago

Affimed Reports 2023 Financial Results and Operational Progress

Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024

AFMD

GlobeNewswire

a year ago

Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024

AFMD

Zacks

a year ago

Affimed N.V. (AFMD) Upgraded to Buy: Here's What You Should Know

7 of the Best Speculative Stocks You Can Snag for Less Than $1

AFMD

InvestorPlace

a year ago

7 of the Best Speculative Stocks You Can Snag for Less Than $1

Affimed Announces 1-for-10 Reverse Stock Split

AFMD

GlobeNewswire

a year ago

Affimed Announces 1-for-10 Reverse Stock Split

Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

AFMD

GlobeNewswire

a year ago

Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

Amgen Inc. (AMGN) Soars to 52-Week High, Time to Cash Out?

AFMD

Zacks

a year ago

Amgen Inc. (AMGN) Soars to 52-Week High, Time to Cash Out?

AFMD

Business Wire

a year ago

Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population

ChromaDex Corporation's (NASDAQ:CDXC) Shift From Loss To Profit

AFMD

Simply Wall St.

a year ago

ChromaDex Corporation's (NASDAQ:CDXC) Shift From Loss To Profit

SteveWillDoIt Does Safety Shot: One of the Top Influencers on Social Media Partners with Safety Shot, a Wellness Beverage that Reduces Blood Alcohol & Boosts Clarity

AFMD

GlobeNewswire

a year ago

SteveWillDoIt Does Safety Shot: One of the Top Influencers on Social Media Partners with Safety Shot, a Wellness Beverage that Reduces Blood Alcohol & Boosts Clarity

P3 Health Partners Inc.'s (NASDAQ:PIII) Path To Profitability

AFMD

Simply Wall St.

a year ago

P3 Health Partners Inc.'s (NASDAQ:PIII) Path To Profitability

Blink and McArthurGlen Team Up to Provide EV Chargers at Famous Dutch Designer Outlets

AFMD

GlobeNewswire

a year ago

Blink and McArthurGlen Team Up to Provide EV Chargers at Famous Dutch Designer Outlets

Mage Networks Signs Memorandum of Understanding for Telesat Lightspeed Services

AFMD

GlobeNewswire

a year ago

Mage Networks Signs Memorandum of Understanding for Telesat Lightspeed Services

Institutional investors may adopt severe steps after Agenus Inc.'s (NASDAQ:AGEN) latest 16% drop adds to a year losses

AFMD

Simply Wall St.

a year ago

Institutional investors may adopt severe steps after Agenus Inc.'s (NASDAQ:AGEN) latest 16% drop adds to a year losses

AFMD

Zacks

a year ago

Zacks Industry Outlook Highlights Oil States International, Matrix Service and Profire Energy

Blue Foundry Bancorp Schedules Fourth Quarter & Year-End 2023 Earnings Conference Call

AFMD

GlobeNewswire

a year ago

Blue Foundry Bancorp Schedules Fourth Quarter & Year-End 2023 Earnings Conference Call

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

AFMD

GlobeNewswire

a year ago

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

Kingsway to Present at the Sidoti Virtual Investor Conference January 18, 2024 at 12:15pm ET

AFMD

ACCESSWIRE

a year ago

Kingsway to Present at the Sidoti Virtual Investor Conference January 18, 2024 at 12:15pm ET

Mesoblast (ASX:MSB) investors are sitting on a loss of 88% if they invested three years ago

AFMD

Simply Wall St.

a year ago

Mesoblast (ASX:MSB) investors are sitting on a loss of 88% if they invested three years ago

Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer

AFMD

GlobeNewswire

a year ago

Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer

City Office REIT Inc's Dividend Analysis

AFMD

GuruFocus.com

a year ago

City Office REIT Inc's Dividend Analysis

Affimed Announces Leadership Change and Organizational Restructuring

AFMD

GlobeNewswire

a year ago

Affimed Announces Leadership Change and Organizational Restructuring

Citi Trends Announces 2023 Holiday Sales Results for Quarter-to-date Through January 6, 2024

AFMD

Business Wire

a year ago

Citi Trends Announces 2023 Holiday Sales Results for Quarter-to-date Through January 6, 2024

Blackstone Credit Closed-End Funds Announce Trustee and Officer Changes

AFMD

PR Newswire

a year ago

Blackstone Credit Closed-End Funds Announce Trustee and Officer Changes

Why Select Medical (SEM) is a Top Momentum Stock for the Long-Term

AFMD

Zacks

a year ago

Why Select Medical (SEM) is a Top Momentum Stock for the Long-Term

Frequency Electronics, Inc. (NASDAQ:FEIM) is definitely on the radar of institutional investors who own 38% of the company

AFMD

Simply Wall St.

a year ago

Frequency Electronics, Inc. (NASDAQ:FEIM) is definitely on the radar of institutional investors who own 38% of the company

Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck

AFMD

GlobeNewswire

a year ago

Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck

Perfect Corp. Set to Reveal Top AI Tech Trends of 2024 at CES with Game-Changing ‘Beautiful AI’ Innovations Across Beauty, Skincare, Fashion, and Generative AI

AFMD

Business Wire

a year ago

Perfect Corp. Set to Reveal Top AI Tech Trends of 2024 at CES with Game-Changing ‘Beautiful AI’ Innovations Across Beauty, Skincare, Fashion, and Generative AI

Independent Director of Unifi Picks Up 28% More Stock

AFMD

Simply Wall St.

a year ago

Independent Director of Unifi Picks Up 28% More Stock

Osisko Development Announces Management Updates

AFMD

GlobeNewswire

a year ago

Osisko Development Announces Management Updates

Timothy Barberich Bought 41% More Shares In TScan Therapeutics

AFMD

Simply Wall St.

a year ago

Timothy Barberich Bought 41% More Shares In TScan Therapeutics

Kolibri Global Energy Inc. Provides 2023 Guidance Update and Operations Update

AFMD

Business Wire

a year ago

Latest Affimed N.V. (AFMD) News on April 2, 2025

Share on Social Networks: